BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12736274)

  • 21. Increased expression of hepatocyte nuclear factor 6 stimulates hepatocyte proliferation during mouse liver regeneration.
    Tan Y; Yoshida Y; Hughes DE; Costa RH
    Gastroenterology; 2006 Apr; 130(4):1283-300. PubMed ID: 16618419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy.
    Nelsen CJ; Kuriyama R; Hirsch B; Negron VC; Lingle WL; Goggin MM; Stanley MW; Albrecht JH
    J Biol Chem; 2005 Jan; 280(1):768-76. PubMed ID: 15509582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 is up-regulated in hepatocytes in vivo following cell-cycle block induced by retrorsine.
    Pitzalis S; Doratiotto S; Greco M; Montisci S; Pasciu D; Porcu G; Pani P; Laconi S; Laconi E
    J Hepatol; 2005 Sep; 43(3):485-90. PubMed ID: 16023250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytes.
    Troadec MB; Courselaud B; Détivaud L; Haziza-Pigeon C; Leroyer P; Brissot P; Loréal O
    J Hepatol; 2006 Feb; 44(2):391-9. PubMed ID: 16229922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.
    Wu K; Wang C; D'Amico M; Lee RJ; Albanese C; Pestell RG; Mani S
    Mol Cancer Ther; 2002 Jul; 1(9):695-706. PubMed ID: 12479366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
    Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
    Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.
    Goukassian D; Sanz-González SM; Pérez-Roger I; Font de Mora J; Ureña J; Andrés V
    Br J Pharmacol; 2001 Apr; 132(7):1597-605. PubMed ID: 11264255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms.
    Winston JT; Pledger WJ
    Mol Biol Cell; 1993 Nov; 4(11):1133-44. PubMed ID: 8305735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of collagen structure in mitogen stimulation of ERK, cyclin D1 expression, and G1-S progression in rat hepatocytes.
    Fassett JT; Tobolt D; Nelsen CJ; Albrecht JH; Hansen LK
    J Biol Chem; 2003 Aug; 278(34):31691-700. PubMed ID: 12794085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice.
    Chiu H; Gardner CR; Dambach DM; Durham SK; Brittingham JA; Laskin JD; Laskin DL
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):218-27. PubMed ID: 14644624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of cyclin-E(1) via proline-mTOR pathway is responsible for HGF-mediated G(1)/S progression in the primary culture of rat hepatocytes.
    Oka K; Ohya-Shimada W; Mizuno S; Nakamura T
    Biochem Biophys Res Commun; 2013 May; 435(1):120-5. PubMed ID: 23618858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration.
    Schwabe RF; Bradham CA; Uehara T; Hatano E; Bennett BL; Schoonhoven R; Brenner DA
    Hepatology; 2003 Apr; 37(4):824-32. PubMed ID: 12668975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine inhibits growth through the activating transcription factor/cAMP-responsive element-binding protein binding site in the cyclin D1 promoter.
    Schneider G; Oswald F; Wahl C; Greten FR; Adler G; Schmid RM
    J Biol Chem; 2002 Nov; 277(46):43599-607. PubMed ID: 12215435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration.
    Li W; Liang X; Kellendonk C; Poli V; Taub R
    J Biol Chem; 2002 Aug; 277(32):28411-7. PubMed ID: 12032149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes.
    Thevananther S; Sun H; Li D; Arjunan V; Awad SS; Wyllie S; Zimmerman TL; Goss JA; Karpen SJ
    Hepatology; 2004 Feb; 39(2):393-402. PubMed ID: 14767992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats.
    Funakoshi F; Masaki T; Kita Y; Hitomi M; Kurokohchi K; Uchida N; Watanabe S; Yoshiji H; Kuriyama S
    Int J Mol Med; 2004 Jun; 13(6):779-87. PubMed ID: 15138612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2.
    Nelsen CJ; Hansen LK; Rickheim DG; Chen C; Stanley MW; Krek W; Albrecht JH
    Oncogene; 2001 Apr; 20(15):1825-31. PubMed ID: 11313930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli.
    Ledda-Columbano GM; Pibiri M; Concas D; Cossu C; Tripodi M; Columbano A
    Hepatology; 2002 Nov; 36(5):1098-105. PubMed ID: 12395319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated growth of hepatocytes in association with Up-regulation of cyclin E in transgenic mice expressing the dominant negative form of retinoic acid receptor.
    Tsutusmi A; Shiota G; Yamazaki H; Kunisada T; Terada T; Kawasaki H
    Biochem Biophys Res Commun; 2000 Nov; 278(1):229-35. PubMed ID: 11071877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.